Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells

Oct 6, 2016Genetics and molecular research : GMR

Ginsenoside Rg1’s effects on aging in blood vessel muscle cells

AI simplified

Abstract

Ginsenoside Rg1 significantly reduced the proportion of senescent vascular smooth muscle cells (VSMCs) compared to the D-galactose group.

  • D-galactose treatment increased the number of senescent VSMCs, as indicated by a rise in b-galactosidase-positive cells.
  • Ultrastructural changes in VSMCs were observed after D-galactose treatment.
  • The expression of cell cycle regulators p16, p21, and p53 was significantly elevated in the D-galactose group.
  • Rg1 treatment led to a significant decrease in senescent VSMCs and reduced levels of p16, p21, and p53 expression.
  • Cell cycle arrest in the G0/G1 phase was less pronounced in Rg1-treated cells compared to those treated with D-galactose.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free